Showing posts with label tissue engineering. Show all posts
Showing posts with label tissue engineering. Show all posts

Thursday, February 01, 2007

Breathing life into artificial organs

  • 01 February 2007
  • From New Scientist Print Edition. Subscribe and get 4 free issues
  • Celeste Biever

Jeff Borenstein holds up a piece of semi-transparent rubber, about half the size of a credit card. If all goes to plan this unassuming piece of rubber could become the building block for the first 3D artificial organs.

reposted from: New Scientist
my highlights / edits

Stacks of these bendy, biodegradable flaps are fused together to form structures snaked through with a network of interconnecting channels. When pumped with a solution of cells, nutrients and oxygen, these channels spring into life, forming a system of blood vessels and tissue that might one day be the basis of an artificial heart, kidney or liver.

Borenstein, a micro-machinist at the Draper Laboratory in Cambridge, Massachusetts, is just one of a number of people who are attempting to build sophisticated artificial organs complete with their own network of blood vessels, or vasculature.

So far simple organs including skin and bladders have been built by seeding a tissue scaffold with cells that are cultured in a nutrient-rich broth. Skin and bladder tissue is thin enough for oxygen and nutrients from the broth to reach all the cells, and a dedicated vascular system is unnecessary until the organs are transplanted when the body's own blood vessels take over.

But thicker organs such as the liver, heart and kidneys will need a vascular system while they grow in the lab, otherwise cells beneath the surface will die from lack of oxygen. "The major limiting factor for solid organs right now is vascularity," says Anthony Atala, a tissue engineer at Wake Forest University in Winston-Salem, North Carolina, who last year implanted the first lab-grown bladders in humans (New Scientist, 8 April 2006, p 10).

"The major limiting factor for solid organs right now is a vascular system"

Borenstein's solution is to create a temporary scaffold of biodegradable polymer containing a network of channels, some of which become organ tissue and others blood vessels. The two sets of channels are linked via small pores, allowing nutrients and oxygen pumped through the blood vessels to reach the liver or heart tissue. "Channels help you to establish the organ and maintain function," he says. When the organ is implanted, these channels would be connected to the recipient's own blood vessels.

To create the channels, which are around 10 micrometres in diameter, Borenstein uses a process called soft lithography. A piece of silicon is etched as if to create a reverse cast of the channels, so when the biodegradable material is poured onto the "mould" and removed it has the desired shape. Two halves are fused together and then connected to other copies to create a network of channels (see picture).

So far Borenstein has created 8-centimetre cubes from a range of biodegradable materials, including dissolved spider silk and a polymer called polyglycerol-sebacate, or "biorubber". He can tune the scaffold to the needs of particular organs by using materials with different properties. For instance, cells that take a long time to grow will need a scaffold that degrades slowly after implantation and retains its structure, while others might require a structure that dissolves quickly.

To turn some channels into blood vessels Borenstein lines them with endothelial cells; for liver organ tissue he fills channels with liver cells called hepatocytes. He has also built 2-millimetre-sized hybrid cubes, seeded with both cell types, which filter blood in a similar way to the liver. The blood travels along a "vessel" lined with a single layer of endothelial cells, and passes through the pores into a layer of hepatocytes. These filter the blood and return it to the original vessel.

However, while building a simple cube of cell-lined channels is relatively straightforward, ensuring cells migrate throughout an entire organ so that they fill gaps between these channels may prove more difficult. "This is particularly critical for cells that don't divide or migrate readily like hepatocytes," says Sangeeta Bhatia, a tissue engineer at the Massachusetts Institute of Technology.

Bhatia is pursuing a different approach. Instead of flowing cells through a ready-made structure, she mixes liver cells with a light-sensitive polymer called polyethylene glycol, which she deposits on a surface and covers with a mask. She can build very precise structures by shining light onto the cell-filled polymer to harden those areas not covered by the mask and then washing the rest away (New Scientist, 4 January 2003, p 19). "We build living tissues with light rather than fabricating a scaffold and then occupying it with cells," Bhatia says. "This allows us to embed cells throughout the organ without coaxing the cells to migrate."

She has already used the technique to create liver tissue a few millimetres thick, a breakthrough that will appear in the Journal of the Federation of American Societies for Experimental Biology (FASEB). Although she did not build an entire vascular system to feed the tissue, she did create a network of channel-like voids - 50 micrometres wide - between the liver cells, through which she pumped a fluid rich in oxygen and nutrients. This kept the tissue alive for 10 days. "If we organised these voids into a branching network explicitly, it would look like a vascular system," she says.

Some researchers, however, doubt whether either technique will ever produce structures as intricate as those in the human body, where arteries and veins branch hundreds of times until they form tiny structures just 10 micrometres wide. "They could build such a branching structure but this is very complicated, so I have strong reservations," says Gabor Forgacs at the University of Missouri-Columbia. Forgacs believes that engineering the thicker vessels but leaving the smaller ones to develop on their own might prove more successful.

A group lead by Jens Kelm and Martin Fussenegger of the Swiss Federal Institute of Technology in Zurich has shown that cells can build their own vasculature. Last year they created balls of a mixture of animal and human heart cells and coated them with human umbilical vein endothelial cells. They found that as the heart cells on the inside ran short of oxygen, they released a chemical called VEGF that prompted the endothelial cells to migrate to the centre of the ball and form a network of cells resembling capillaries. When they attached a tissue made of multiple balls to a chicken embryo, the embryo blood vessels fused with those in the grafted tissue, showing that a vasculature formed like this could one day be hooked up to the human body.

But Forgacs believes it would not be possible for an entire heart to form in this way, as they are far too complex. Instead he hopes to combine this approach with a bioprinting technique he has developed. He uses a centrifuge to form clumps of cells, which are printed layer by layer onto a biodegradable gel to build 3D structures (New Scientist, 13 April 2006, p 19). He plans to print large tubes of cells to build veins and arteries, and he hopes the smaller vessels will form by themselves from clumps of heart or liver cells coated in endothelial cells in the space surrounding the larger vessels. Indeed, many of the new techniques being developed are likely to merge as more is learned about how to create the complex networks of cells needed to form hearts, livers and kidneys.

"It's a really exciting time because we are all learning the principles," says David Kaplan at Tufts University in Medford, Massachusetts. "If we can succeed, the impact on human health is immense."

From issue 2589 of New Scientist magazine, 01 February 2007, page 24-25

Saturday, December 30, 2006

Tissue Engineering will give limb regeneration

Ellen Heber-Katz forecasts the future

  • 18 November 2006
I believe that the day is not far off when we will be able to prescribe drugs that cause severed spinal cords to heal, hearts to regenerate and lost limbs to regrow. People will come to expect that injured or diseased organs are meant to be repaired from within, in much the same way that we fix an appliance or automobile: by replacing the damaged part with a manufacturer-certified new part.

Advances in heart regeneration are around the corner, digits will be regrown within five to ten years, and limb regeneration will occur a few years later. Central nervous system repair will occur first with the retina and optic nerve and later with the spinal cord. Within 50 years whole-body replacement will be routine.

Friday, December 29, 2006

the Bladder is the first human organ ever grown in the lab and transplanted into patients

  • my edits in bold
  • 08 April 2006
  • Peter Aldhous
  • Andy Coghlan
  • Roxanne Khamsi

IT IS being hailed as a landmark in tissue engineering. Seven youngsters who faced a future of incontinence and serious kidney problems have been given new bladders grown in the lab from their own cells, and grafted onto their existing bladders.

Researchers in regenerative medicine are impressed by the results, which were announced this week by Anthony Atala of Wake Forest University in Winston-Salem, North Carolina. "This is the first human organ ever grown in the laboratory and transplanted into patients," says Bob Lanza, head of scientific development at Advanced Cell Technology in Worcester, Massachusetts. "It's the beginning of a new medical era."

Maybe so, but tissue engineers warn that it will be years before they crack the problem of growing more complex, solid organs, such as kidneys and hearts. And Atala's technique does not yet match the results of conventional surgical treatment for severe bladder problems. "It's pioneering work," says Stéphane Bolduc, a paediatric urologist at Laval University in Quebec City, Canada. "But clinically, I'm not yet convinced."

In the late 1990s, while at Harvard Medical School in Boston, Atala replaced dogs' bladders with organs grown from scratch (New Scientist, 13 June 1998, p 16). This week, his team reported on seven people who were all born with spina bifida, which left them with shrunken bladders missing normal nervous connections. They were incontinent, and the fluid in their bladders was at dangerously high pressure, which can damage the kidneys. Between the ages of 4 and 19 they were given lab-grown bladders, and have now had the engineered organs for an average of four years (The Lancet, DOI: 10.1016/S0140-673(06)68438-9).

Atala and his colleagues first took a biopsy from each person's bladder, containing about one million cells. These cells were grown in culture for a month, until they had multiplied to around 1.5 billion cells, and were then seeded onto a sac-shaped "scaffold" made of collagen, a structural protein found in most of our tissues. In some cases this was mixed with polyglycolic acid, a biodegradable material used in surgical stitches. After being grown for a further two months, the engineered bladders were grafted onto the patients' own.

The patients' cultured cells were seeded onto a sac-like scaffold of collagen and then grown for a further two months

The usual treatment to fix defective bladders is to cut out a section of a person's small intestine and graft this onto the bladder. However, this can cause complications, including the secretion of mucus from the intestinal tissue into the bladder, which can lead to urinary infections and bladder stones. Atala's patients didn't have these problems, and their bladder function improved. In general, the organ's overall capacity went up and the pressure inside it went down. Rather than leaking urine almost continuously, the patients could remain dry for several hours at a time, although because they still lacked normal nervous connections, they did not gain full bladder control.

It is an encouraging start, says Bolduc, who is also working on tissue-engineered bladders. But he says the gains in capacity and reductions in pressure reported by Atala's team are still less than conventional surgery can achieve.

Atala admits that he still has some work to do. One goal is to grow a complete bladder, offering hope for cancer patients who must have the entire organ removed. This will require sophisticated surgery to connect the ureters, the tubes that carry urine from the kidneys. It also means growing the sphincter that normally seals the organ shut, opening only when we urinate. "We are actually making sphincter muscles now," Atala says.

Surgical tricks learned with these first bladders should help in future attempts to replace the entire bladder. Atala's best results came when he wrapped the grafts with omentum, a flap of fatty tissue that normally sits over the front of the intestines. It is rich in blood vessels, and seemed to help the grafts establish a blood supply.

Getting a good blood supply is also a key obstacle to researchers trying to grow solid organs, such as hearts and kidneys, and they must find a way to infuse nutrients into the growing structures.

From issue 2546 of New Scientist magazine, 08 April 2006, page 10